Abbot (NYSE: ABT) has completed its acquisition of Guidant’s vascular business giving birth to one of the leading global vascular devices companies. This combined Abbott-Guidant business offers a broad line of leading coronary and endovascular products which will transform the way physicians treat vascular disease, in turn making an impact to the lives of millions of patients worldwide.
"The acquisition of Guidant's vascular business builds on our broad-based business strategy to develop leading positions in attractive health care markets - shaping Abbott for greater balance and strengthening our business mix and breadth of pipeline opportunities," said Miles D. White, chairman and chief executive officer, Abbott.
This acquisition was made in connection with Boston Scientific’s (NYSE: BSX) acquisition of Guidant Corporation (NYSE: GDT).
Read more.
Comment Preview